Concepedia

Carol L. Broderick

CL

Statistics

Publications

13

Citations

1.1K

H-Index

13

Active since

1991

Affiliations

Eli Lilly (United States)(Current)

Ligand Pharmaceuticals (United States)

University of Waterloo

Carol L. Broderick is an author at Eli Lilly (United States) specializing in pharmacology, life sciences, and molecular pharmacology.

Publications per year

1991–2012

13

Publications

13

Antidiabetic Action of a Liver X Receptor Agonist Mediated By Inhibition of Hepatic Gluconeogenesis

Guoqing Cao, Liang Yu, Carol L. Broderick et al. · Journal of Biological Chemistry · 2003 · 293 citations · Full text

, , +17

Circulating αKlotho influences phosphate handling by controlling FGF23 production

Rosamund C. Smith, Linda M. O’Bryan, Emily Farrow et al. · Journal of Clinical Investigation · 2012 · 149 citations

, , +17

A Tailored Therapy for the Metabolic Syndrome

Garret J. Etgen, Brian A. Oldham, W. Thomas Johnson et al. · Diabetes · 2002 · 105 citations · Full text

, , +17

Neglected Time: Impaired Temporal Perception of Multisecond Intervals in Unilateral Neglect

James Danckert, Susanne Ferber, Carson Pun et al. · Journal of Cognitive Neuroscience · 2007 · 96 citations

, , +7

Biological Characterization of a Heterodimer-Selective Retinoid X Receptor Modulator: Potential Benefits for the Treatment of Type 2 Diabetes

Mark D. Leibowitz, Robert Ardecky, Marcus F. Boehm et al. · Endocrinology · 2005 · 70 citations · Full text

, , +15

1–5 of 13